Search Results - "Fromm Longo, Jody"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    LPAR1 and aberrantly expressed LPAR3 differentially promote the migration and proliferation of malignant peripheral nerve sheath tumor cells by Doutt, Shannon Weber, Longo, Jody Fromm, Carroll, Steven L.

    Published in Glia (01-03-2023)
    “…Schwann cell‐derived neoplasms known as malignant peripheral nerve sheath tumors (MPNSTs) are the most common malignancy and the leading cause of death in…”
    Get full text
    Journal Article
  2. 2

    Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models by Jenkins, Dorea P, Turner-Ivey, Brittany, Fromm Longo, Jody, Carroll, Steven L

    Published in Journal of visualized experiments (17-05-2024)
    “…Patients with the autosomal dominant tumor susceptibility syndrome neurofibromatosis type 1 (NF1) commonly develop plexiform neurofibromas (PNs) that…”
    Get more information
    Journal Article
  3. 3

    Establishment and genomic characterization of a sporadic malignant peripheral nerve sheath tumor cell line by Longo, Jody Fromm, Brosius, Stephanie N., Znoyko, Iya, Alers, Victoria A., Jenkins, Dorea P., Wilson, Robert C., Carroll, Andrew J., Wolff, Daynna J., Roth, Kevin A., Carroll, Steven L.

    Published in Scientific reports (11-03-2021)
    “…Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive Schwann cell-derived neoplasms that occur sporadically or in patients with neurofibromatosis…”
    Get full text
    Journal Article
  4. 4

    R-Ras subfamily proteins elicit distinct physiologic effects and phosphoproteome alterations in neurofibromin-null MPNST cells by Weber, Shannon M, Brossier, Nicole M, Prechtl, Amanda, Barnes, Stephen, Wilson, Landon S, Brosius, Stephanie N, Longo, Jody Fromm, Carroll, Steven L

    Published in Cell communication and signaling (16-09-2021)
    “…Loss of the Ras GTPase-activating protein neurofibromin promotes nervous system tumor pathogenesis in patients with neurofibromatosis type 1 (NF1)…”
    Get full text
    Journal Article
  5. 5

    ErbB4 promotes malignant peripheral nerve sheath tumor pathogenesis via Ras-independent mechanisms by Longo, Jody Fromm, Brosius, Stephanie N, Black, Laurel, Worley, Stuart H, Wilson, Robert C, Roth, Kevin A, Carroll, Steven L

    Published in Cell communication and signaling (10-07-2019)
    “…We have found that erbB receptor tyrosine kinases drive Ras hyperactivation and growth in NF1-null malignant peripheral nerve sheath tumors (MPNSTs). However,…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The RASopathies: Biology, genetics and therapeutic options by Longo, Jody Fromm, Carroll, Steven L

    Published in Advances in cancer research (2022)
    “…The RASopathies are a group of genetic diseases in which the Ras/MAPK signaling pathway is inappropriately activated as a result of mutations in genes encoding…”
    Get full text
    Journal Article
  8. 8

    Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor by Turner-Ivey, Brittany, Longo, Jody Fromm, Jenkins, Dorea P, Guest, Stephen T, Carroll, Steven L

    Published in Journal of visualized experiments (25-08-2023)
    “…Malignant Peripheral Nerve Sheath Tumors (MPNSTs) are derived from Schwann cells or their precursors. In patients with the tumor susceptibility syndrome…”
    Get more information
    Journal Article
  9. 9

    Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms by Longo, Jody F, Weber, Shannon M, Turner-Ivey, Brittany P, Carroll, Steven L

    Published in Advances in anatomic pathology (01-09-2018)
    “…The diagnosis of a neurofibroma or a malignant peripheral nerve sheath tumor (MPNST) often raises the question of whether the patient has the genetic disorder…”
    Get full text
    Journal Article
  10. 10
  11. 11